Earnings
Companies that generate revenue less than $100 million would not have to undergo regular outside audits.
MyoKardia, Inc. reported financial results for the quarter ended March 31, 2019.
BioArctic’s partner Eisai initiated Phase 3-study with BAN2401 in Alzheimer’s disease.
Expedeon AG reported results for the first quarter ended March 31, 2019.
Assertio Therapeutics, Inc. reported financial results for the quarter ended March 31, 2019, and provided an update on its business performance and strategic initiatives.
TLC announced financial results for the first quarter ended March 31, 2019, and provided a business update.
Esperion provided bempedoic acid franchise development program updates and financial results for the first quarter ended March 31, 2019.
Epigenomics AG announced the financial results for the first quarter of the FY 2019.
With key investors upset about Allergan’s share price, Saunders pointed to five potential drugs on the market within the next 18 months.
Vericel Corporation reported financial results for the first quarter ended March 31, 2019, and recent business highlights.
PRESS RELEASES